Literature DB >> 21252153

TRPC channels as effectors of cardiac hypertrophy.

Petra Eder1, Jeffery D Molkentin.   

Abstract

Transient receptor potential (TRP) channels of multiple subclasses are expressed in the heart, although their functions are only now beginning to emerge, especially for the TRPC subclass that appears to regulate the cardiac hypertrophic response. Although TRP channels permeate many different cations, they are most often ascribed a specific biological function because of Ca(2+) influx, either for microdomain signaling or to reload internal Ca(2+) stores in the endoplasmic reticulum through a store-operated mechanism. However, adult cardiac myocytes arguably do not require store-operated Ca(2+) entry to regulate sarcoplasmic reticulum Ca(2+) levels and excitation-contraction coupling; hence, TRP channels expressed in the heart most likely coordinate signaling within local domains or through direct interaction with Ca(2+)-dependent regulatory proteins. Here, we review the emerging evidence that TRP channels, especially TRPCs, are critical regulators of microdomain signaling in the heart to control pathological hypertrophy in coordination with signaling through effectors such as calcineurin and NFAT (nuclear factor of activated T cells).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252153     DOI: 10.1161/CIRCRESAHA.110.225888

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  87 in total

1.  A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility.

Authors:  Catherine A Makarewich; Robert N Correll; Hui Gao; Hongyu Zhang; Baohua Yang; Remus M Berretta; Victor Rizzo; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

Review 2.  STIM/Orai signalling complexes in vascular smooth muscle.

Authors:  Mohamed Trebak
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

Review 3.  Biomechanics of cardiac electromechanical coupling and mechanoelectric feedback.

Authors:  Emily R Pfeiffer; Jared R Tangney; Jeffrey H Omens; Andrew D McCulloch
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

4.  Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip.

Authors:  Megan L McCain; Sean P Sheehy; Anna Grosberg; Josue A Goss; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

Review 5.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  Location and function of transient receptor potential canonical channel 1 in ventricular myocytes.

Authors:  Qinghua Hu; Azmi A Ahmad; Thomas Seidel; Chris Hunter; Molly Streiff; Linda Nikolova; Kenneth W Spitzer; Frank B Sachse
Journal:  J Mol Cell Cardiol       Date:  2020-01-23       Impact factor: 5.000

Review 7.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

8.  Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy.

Authors:  Kinya Seo; Peter P Rainer; Virginia Shalkey Hahn; Dong-Ik Lee; Su-Hyun Jo; Asger Andersen; Ting Liu; Xiaoping Xu; Robert N Willette; John J Lepore; Joseph P Marino; Lutz Birnbaumer; Christine G Schnackenberg; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-22       Impact factor: 11.205

9.  Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.

Authors:  Worawan B Limpitikul; Ivy E Dick; Rosy Joshi-Mukherjee; Michael T Overgaard; Alfred L George; David T Yue
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

10.  Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.

Authors:  Jung Woo Han; Young Ho Lee; Su-In Yoen; Joel Abramowitz; Lutz Birnbaumer; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.